Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience

Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease of uncertain cause, and its manifestations appear to vary by race and ethnicity. The literature on AIH in the Middle East, including Jordan, is scarce; therefore, this study aimed to determine the clinical characteristics of AIH in an understudied population. This retrospective chart review study was conducted on AIH patients who presented to Jordan University Hospital over a seven-year period (2014–2020). Retrieved data included sociodemographics, liver function tests, autoimmune serologic markers, viral hepatitis serology, findings on liver biopsies, treatment regimens, post-therapy outcomes and treatment-related complications. The total number of AIH patients included in the study was 30, divided as follows: type 1 AIH (n = 17, 56.7%), type 2 AIH (n = 2, 6.7%), seronegative AIH (n = 9, 30.0%), and two patients who had AIH-primary biliary cirrhosis overlap syndrome (6.7%). The mean age at diagnosis was 44 years (standard deviation: 17 years), with a female predominance (n = 25, 83.3%). Acute presentation was seen among 18 patients (60.0%). Mild to moderate fibrosis (F1 and F2 on METAVIR scoring system) without cirrhosis was observed among patients who underwent liver biopsies (10/19, 52.6%). The majority of patients (73.3%) were initially treated with prednisone, with azathioprine combination in 16.7% of the patients. At 6 months post initial treatment, twenty patients (66.7%) achieved biochemical remission, four patients had incomplete response, two patients failed to improve (one died during the induction of remission period due to AIH-related complications), and four patients were lost to follow-up. This study provided an updated overview of AIH in Jordan. The results showed typical female predominance, and interestingly high rates of acute presentation and seronegative disease. Future longitudinal studies are recommended to address the nature and long-term prognosis of AIH in Jordan.

[1]  A. Czaja Diagnosis and management of autoimmune hepatitis , 2015, BMJ.

[2]  Kosha J. Mehta,et al.  Liver biopsy for assessment of chronic liver diseases: a synopsis , 2022, Clinical and Experimental Medicine.

[3]  A. Mahafzah,et al.  Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa , 2021, Pathogens.

[4]  D. Vergani,et al.  Autoimmmune hepatitis , 2021, Cellular & Molecular Immunology.

[5]  V. de Lédinghen,et al.  NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF AUTOIMMUNE HEPATITIS. , 2021, Clinics and research in hepatology and gastroenterology.

[6]  E. Gadour Autoimmune Hepatitis: Treatment Options and Management Review , 2021, Cureus.

[7]  E. Atkinson,et al.  Environmental risk factors are associated with autoimmune hepatitis , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[8]  A. Komori Recent updates on the management of autoimmune hepatitis , 2020, Clinical and molecular hepatology.

[9]  K. Talari,et al.  Retrospective Studies – Utility and Caveats , 2020, The journal of the Royal College of Physicians of Edinburgh.

[10]  G. Coral,et al.  EVALUATION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A SPECIALIZED OUTPATIENT CLINIC IN SOUTHERN BRAZIL. , 2020, Arquivos de gastroenterologia.

[11]  G. Cooper,et al.  Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019 , 2020, Journal of clinical gastroenterology.

[12]  G. Hirschfield,et al.  The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude , 2020, medRxiv.

[13]  J. Kaler,et al.  The Prevalence of Autoimmune Disorders in Women: A Narrative Review , 2020, Cureus.

[14]  A. Mahafzah,et al.  An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman , 2019, BMC Infectious Diseases.

[15]  M. Manns,et al.  Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases , 2019, Hepatology.

[16]  D. Gleeson Long‐Term Outcomes of Autoimmune Hepatitis , 2019, Clinical liver disease.

[17]  S. John,et al.  Autoimmune hepatitis: Appraisal of current treatment guidelines , 2018, World journal of hepatology.

[18]  B. van Hoek,et al.  Role of age in presentation, response to therapy and outcome of autoimmune hepatitis , 2018, Clinical and Translational Gastroenterology.

[19]  T. Liwinski,et al.  Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance , 2018, Front. Immunol..

[20]  Xiong Ma,et al.  Autoimmune Hepatitis in the Asia-Pacific Area , 2017, Journal of clinical and translational hepatology.

[21]  O. Behairy Characteristics of autoimmune hepatitis in a sample of Egyptian children , 2017 .

[22]  D. Vergani,et al.  Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments , 2017, World journal of gastroenterology.

[23]  A. Czaja Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis , 2017, Digestive Diseases and Sciences.

[24]  S. Mohanty,et al.  Seronegative Autoimmune Hepatitis A Clinically Challenging Difficult Diagnosis , 2017, Case reports in medicine.

[25]  G. Hirschfield,et al.  EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. , 2017, Journal of hepatology.

[26]  C. Grant,et al.  Liver immunology: How to reconcile tolerance with autoimmunity. , 2017, Clinics and research in hepatology and gastroenterology.

[27]  E. Lubberts,et al.  Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential , 2017, Front. Immunol..

[28]  Atsushi Hokari,et al.  Autoimmune hepatitis: current challenges and future prospects , 2017, Clinical and experimental gastroenterology.

[29]  Ç. Ecevit,et al.  Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience , 2016, European journal of gastroenterology & hepatology.

[30]  M. Ota,et al.  Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[31]  P. Gaglio,et al.  Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population , 2016, Gastroenterology and hepatology from bed to bench.

[32]  M. Gershwin,et al.  The clinical phenotypes of autoimmune hepatitis: A comprehensive review. , 2016, Journal of autoimmunity.

[33]  H. Vilstrup,et al.  Worldwide Incidence of Autoimmune Liver Disease , 2015, Digestive Diseases.

[34]  D. Amarapurkar,et al.  Autoimmune hepatitis in India: single tertiary referral centre experience. , 2015, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[35]  J. Jia,et al.  Autoimmune hepatitis: East meets west , 2015, Journal of gastroenterology and hepatology.

[36]  D. Vergani,et al.  Update on Autoimmune Hepatitis , 2015, Journal of clinical and translational hepatology.

[37]  G. Dalekos,et al.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. , 2015, World journal of gastroenterology.

[38]  V. Novack,et al.  Autoimmune hepatitis in southern Israel: A 15‐year multicenter study , 2013, Journal of digestive diseases.

[39]  D. Vergani,et al.  Clinical significance of autoantibodies in autoimmune hepatitis. , 2013, Journal of autoimmunity.

[40]  M. Peters,et al.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. , 2013, Gastroenterology & hepatology.

[41]  A. Czaja Diagnosis and management of the overlap syndromes of autoimmune hepatitis. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[42]  C. V. van Nieuwkerk,et al.  Auto immune hepatitis. , 2016, World journal of gastroenterology.

[43]  A. Czaja Autoimmune hepatitis in diverse ethnic populations and geographical regions , 2013, Expert review of gastroenterology & hepatology.

[44]  M. Gershwin,et al.  The Implication of Vitamin D and Autoimmunity: a Comprehensive Review , 2013, Clinical Reviews in Allergy & Immunology.

[45]  L. Vonghia,et al.  Epidemiology and treatment of autoimmune hepatitis , 2012, Hepatic medicine : evidence and research.

[46]  R. Malekzadeh,et al.  Clinical Features and Long Term Outcome of 102 Treated Autoimmune Hepatitis Patients , 2012, Hepatitis monthly.

[47]  A. Makol,et al.  Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment , 2011, Hepatitis research and treatment.

[48]  A. Czaja Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis , 2011, Digestive Diseases and Sciences.

[49]  Xiong Ma [The diagnosis and treatment of autoimmune hepatitis]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[50]  H. Fallatah,et al.  Autoimmune Hepatitis: Single-center Experience of Clinical Presentation, Response to Treatment and Prognosis in Saudi Arabia , 2010, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[51]  P. Galle,et al.  Concurrent Autoimmune Diseases in Patients With Autoimmune Hepatitis , 2010, Journal of clinical gastroenterology.

[52]  K. Boberg,et al.  Simplified criteria for the diagnosis of autoimmune hepatitis , 2008, Hepatology.

[53]  F. Carrilho,et al.  Frequency of Concurrent Autoimmune Disorders in Patients With Autoimmune Hepatitis: Effect of Age, Gender, and Genetic Background , 2008, Journal of clinical gastroenterology.

[54]  A. Bergquist,et al.  Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study , 2008, Scandinavian journal of gastroenterology.

[55]  A. Czaja,et al.  Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly , 2006, Hepatology.

[56]  G. Choudhuri,et al.  Autoimmune hepatitis in India: profile of an uncommon disease , 2005, BMC gastroenterology.

[57]  T. Arenovich,et al.  Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome , 2005, Hepatology.

[58]  A. Czaja,et al.  Genetic distinctions between autoimmune hepatitis in Italy and North America. , 2005, World journal of gastroenterology.

[59]  D. Vergani,et al.  Mechanisms of autoimmune hepatitis , 2004, Pediatric transplantation.

[60]  P. Donaldson,et al.  Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. , 2002, Journal of hepatology.

[61]  O. Chazouilleres,et al.  Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy , 1998, Hepatology.

[62]  M. Manns,et al.  Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. , 1992, Gastroenterology.

[63]  K. Meyer zum Büschenfelde,et al.  Autoimmune hepatitis--an update. , 1992, Behring Institute Mitteilungen.

[64]  F. Alvarez,et al.  Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis , 1987, Hepatology.

[65]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .